Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity

Journal of Clinical Virology

Volumn 41, Issue 4, 2008, Pages 288-292

  Suligoi, Barbara ^a   Buttò, Stefano ^a   Galli, Claudio ^b   Bernasconi, Daniela ^a   Salata, Robert A ^c   Tavoschi, Lara ^a   Chiappi, Michele ^a   Mugyenyi, Peter ^d   Pimpinelli, Fulvia ^e   Kityo, Cissy ^d   Regine, Vincenza ^a   Rezza, Giovanni ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b ABBOTT DIAGNOSTICS   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOINT CLINICAL RESEARCH CENTRE   (Uganda)

^e SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

Africa; AIDS; Antibody avidity; HIV; Incidence

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

AFRICAN AMERICAN; ANTIBODY AFFINITY; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROCONVERSION; SEROTYPE; SERUM; STATISTICAL SIGNIFICANCE; UGANDA;

ANTIBODY AFFINITY; FEMALE; GENOTYPE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INCIDENCE; MALE; SENSITIVITY AND SPECIFICITY; SEROTYPING; TIME FACTORS; UGANDA;

EID: 40849100485     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.020     Document Type: Article

References (19)

1. Abbott GmbH. Abbott AxSYM HIV 1/2gO package insert (R4) (2006), Abbott GmbH Diagnostics, Wiesbaden-Delkenheim, Germany
2. Barin F., Lahbabi Y., Buzeley L., Lejeune B., Baillou-Beaufils A., Denis F., et al. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Res Hum Retroviruses 12 (1996) 1279-1289
3. Barin F., Meyer L., Lancar R., Deveau C., Gharib M., Laporte A., et al. Development and validation of an immunoassay for identification of recent human immunodeficiency virus type 1 infections and its use on dried serum spots. J Clin Microbiol 43 (2005) 4441-4447
4. Calypte Biomedical Corporation. Calypte HIV-1 BED incidence EIA (IgG- Capture HIV-EIA) package insert (2004), Calypte Biomedical Corporation, Rockville, MD, USA
5. Cheingsong-Popov R., Lister S., CallowD, Kaleebu P., Beddows S., and Weber J. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genome. AIDS Res Hum Retroviruses 10 (1994) 1379-1386
6. Dobbs T., Kennedy S., Pau C.P., McDougal J.S., and Parekh B.S. Performance characteristics of the immunoglobulin G-capture BED-EIA, an assay to detect recent human immunodeficiency virus type 1 seroconversion. J Clin Microbiol 42 (2004) 2623-2628
7. Hanley J., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
8. Janssen R.S., Satten G.A., Stramer S.L., Rawal B.D., O'Brien T.R., Weiblen B.J., et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 280 (1988) 42-48
9. Kothe D., Byers R.H., Caudill S.P., Satten G.A., Janssen R.S., Hannon W.H., et al. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 33 (2003) 625-634
10. Martrò E., et al. Comparison of the avidity index method and the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion, two methods using a single serum sample for identification of recent HIV infections. J Clin Microbiol 43 (2005) 6197-6199
11. Morrison C.S., Richardson B.A., Mmiro F., Chipato T., Celentano D.D., Lucto J., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007) 85-95
12. Morrison C.S., Wang J., Van Der Pol B., Padian N., Salata R.A., and Richardson B.A. Pregnancy and the risk of HIV acquisition. AIDS 21 (2007) 1027-1034
13. Narayanan S. The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 113 (2000) 429-452
14. Parekh B.S., and McDougal J.S. Application of laboratory methods for estimation of HIV-1 incidence. Indian J Med Res 121 (2005) 510-518
15. Suligoi B., Massi M., Galli C., Sciandra M., Di Sora F., Pezzotti P., et al. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 32 (2003) 424-428
16. Suligoi B., Bossi V., Regine V., Rodella A., Manca N., and Galli C. The accuracy of different cutoffs for the avidity index of HIV antibodies to identify recent infections [CDC0373]. Presented at: XVI International AIDS Conference. Toronto, Canada (2006)
17. Tavoschi L., Bernasconi D., Chiappi M., Suligoi B., Galli C., Salvi E., et al. Low performance of HIV-1 serotyping in high HIV epidemic geographical areas [PP 1.16]. Presented at: 14th International Symposium on HIV & Emerging Infectious Diseases. Toulon, France (2006)
18. Tongren J.E., Drakeley C.J., McDonald S.L., Reyburn H.G., Manjurano A., Nyka W.M., et al. Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria. Infect Immun 74 (2006) 257-264
19. WHO, Initiating second generation surveillance systems: practical guidelines. UNAIDS/02.45E-WHO/HIV/2002.17, Geneva, August 2002.